HOME >> BIOLOGY >> NEWS
JCI table of contents, 15 October, 2003

odium balance is believed to be a crucial mechanism that permits the excretion of water and electrolytes from the kidney into the urine to be finely balanced with dietary salt intake.

TITLE: Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load

AUTHOR CONTACT:
John N. Lorenz
University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
Phone: (513) 558-3097
Fax: (513) 558-5738
Email: john.lorenz@uc.edu

View the PDF of this article at: https://www.the-jci.org/press/18743.pdf

ACCOMPANYING COMMENTARY:
A novel role for uroguanylin in the regulation of sodium balance

AUTHOR CONTACT:
Leonard R. Forte
University of Missouri, Columbia, Missouri, USA.
Phone: (573) 814-6000
Fax: (573) 814-6551
E-mail: lrf@missouri.edu

View the PDF of this commentary at: https://www.the-jci.org/press/20057.pdf


Immunological tug of war between IL-12 and IL-23

Experimental autoimmune encephalomyelitis (EAE) is an animal model of human multiple sclerosis. Microglia and macrophages that reside within the central nervous system (CNS) are a source of the inflammatory cytokines IL-23 and IL-12. Until recently it was considered that IL-12 was a major mediator in the development of EAE, however within the last year it has been reported that IL-23 and not IL-12 is essential in the development of EAE. Burkhard Becher and colleagues from the University of Zurich, Switzerland, and Dartmouth College, New Hampshire, USA, now show that the p40 subunit, shared by both IL-12 and IL-23, plays a critical role in maintaining encephalitogenicity during the course of this disease. The authors d
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Oct-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... WASHINGTON , March 28, 2017 /PRNewswire/ ... launch single-cell sequencing during the American Association for Cancer ... Convention Center in Washington, D.C. , ... differential gene expression of thousands of cells at the ... Experts on-hand at AACR to discuss ...
(Date:3/28/2017)... 28, 2017 Biostage, Inc. (Nasdaq: ... bioengineered organ implants to treat cancers and other life-threatening ... that Jim McGorry, CEO of Biostage, will ... panel at the MassBio 2017 Annual Meeting ... in Cambrige, Massachussetts. The 3D Printing and BioEngineering ...
(Date:3/28/2017)... March 28, 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) ... report compelling safety and clinical data from its phase 1/2 ... collagen-expressing, hair follicle-derived fibroblasts (RCT-01) as a treatment for Achilles ... ... complete safety profile at 6 months and showed no serious ...
(Date:3/27/2017)... Cousins Properties (NYSE: CUZ ) announced today that ... a 10-year, approximately 125,000 square-foot lease at Corporate Center, a ... Westshore submarket of Tampa, FL. ... Center for their new location in Tampa ... officer of Cousins Properties. "Amgen is a cutting-edge global company ...
Breaking Biology Technology:
Cached News: